Enhanced cardiac protein glycosylation (O-GlcNAc) of selected mitochondrial proteins in rats artificially selected for low running capacity

Virginia L. Johnsen, Darrell D. Belke, Curtis C. Hughey, Dustin S. Hittel, Russell T. Hepple, Lauren G. Koch, Steven L. Britton, Jane Shearer

Research output: Contribution to journalArticle

32 Scopus citations

Abstract

O-linked β-N-acetyl glucosamine (O-GlcNAc) is a posttranslational modification consisting of a single N-acetylglucosamine moiety attached by an O-β-glycosidic linkage to serine and threonine residues of both nuclear and cytosolic proteins. Analogous to phosphorylation, the modification is reversible and dynamic, changing in response to stress, nutrients, hormones, and exercise. Aims of this study were to examine differences in O-GlcNAc protein modification in the cardiac tissue of rats artificially selected for low (LCR) or high (HCR) running capacity. Hyperinsulinemic-euglycemic clamps in conscious animals assessed insulin sensitivity while 2-[14C] deoxyglucose tracked both whole body and tissue-specific glucose disposal. Immunoblots of cardiac muscle examined global O-GlcNAc modification, enzymes that control its regulation (OGT, OGA), and specific proteins involved in mitochondrial oxidative phosphorylation. LCR rats were insulin resistant disposing of 65% less glucose than HCR. Global tissue O-GlcNAc, OGT, OGA, and citrate synthase were similar between groups. Analysis of cardiac proteins revealed enhanced O-GlcNAcylation of mitochondrial Complex I, Complex IV, VDAC, and SERCA in LCR compared with HCR. These results are the first to establish an increase in specific protein O-GlcNAcylation in LCR animals that may contribute to progressive mitochondrial dysfunction and the pathogenesis of insulin resistance observed in the LCR phenotype.

Original languageEnglish (US)
Pages (from-to)17-25
Number of pages9
JournalPhysiological genomics
Volume45
Issue number1
DOIs
StatePublished - Jan 7 2013
Externally publishedYes

    Fingerprint

Keywords

  • Aerobic capacity
  • Clamp
  • Insulin resistance
  • Metabolism
  • Mitochondrial dysfunction
  • Type 2 diabetes

Cite this